CIK: 0001538653 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value ($000): $2,193,836 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 1,707,005 | $939,484 | 42.8% | $107.75 | +405.6% | COM | 225310101 |
| W | WAYFAIR INC | 3,823,239 | $423,538 | 19.3% | $53.95 | +160.9% | CL A | 94419L101 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $390,873 | 17.8% | $81.92 | +141.9% | COM | 981419104 |
| CMPR | CIMPRESS PLC | 3,906,492 | $248,414 | 11.3% | $129.96 | -48.8% | SHS EURO | G2143T103 |
| YELP | YELP INC | 2,909,751 | $99,252 | 4.5% | $30.67 | +12.0% | CL A | 985817105 |
| GIC | GLOBAL INDUSTRIAL COMPANY | 1,279,677 | $41,244 | 1.9% | $32.63 | -7.9% | COM | 37892E102 |
| — | VAPOTHERM INC | 2,557,243 | $35,546 | 1.6% | $30.41 | — | COM | 922107107 |
| — | 23ANDME HOLDING CO | 1,423,829 | $5,453 | 0.2% | $7.98 | — | CLASS A COM | 90138Q108 |
| HUMA | HUMACYTE INC | 625,100 | $4,413 | 0.2% | $6.34 | -8.2% | COM | 44486Q103 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 1,851,851 | $2,852 | 0.1% | $1.03 | +50.5% | COM | 53566P109 |
| SANA | SANA BIOTECHNOLOGY INC | 315,800 | $2,609 | 0.1% | $8.80 | -8.1% | COM | 799566104 |
| — | AGEX THEREPEUTICS INC | 185,185 | $158 | 0.0% | $2.99 | — | COM | 00848H108 |